Clinical trial
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prostate Cancer Screening in Men With Germline BRCA2 Mutations
- Lead sponsor
- Yale University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- November 1, 2019
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer